Skip to content
[P]pubcas
Independent chemical reference Compare
Chemical substance record

Busulfan

55-98-1C6H14O6S2246.306 g/mol

A methanesulfonate ester that is butane-1,4-diol in which the hydrogens of the hydroxy groups are replaced by methanesulfonyl groups. An alkylating antineoplastic agent, it is used for the treatment of chronic myeloid leukemia (although it has been largely replaced by newer drugs). It is also used as an insect sterilant. — ChEBI

Safety references

Safety documents & references

1 indexed references
JP · NITE

Government GHS classification

21A3728 · FY2009

View classification

Find a product-specific SDS

Safety guides and government classification records are not a manufacturer’s SDS. Match supplier, product number, concentration, physical form, region and revision before using a document.

Identity & molecular properties

Source-linked values
CAS number55-98-1ChEBI ↗
Molecular formulaC6H14O6S2ChEBI ↗
Molar mass246.306 g/molChEBI ↗
Monoisotopic mass246.02318 DaChEBI ↗
Formal charge0ChEBI ↗
ChEBI identifierCHEBI:28901ChEBI ↗

Cross-source molecular data

PubChem
Molar mass246.3 g/molPubChem ↗
Exact mass246.02318051 DaPubChem ↗
Computed XLogP-0.5PubChem ↗
Topological polar surface area (Ų)104PubChem ↗
H-bond donors0PubChem ↗
H-bond acceptors6PubChem ↗
Rotatable bonds7PubChem ↗

PubChem computed values are shown separately from the ChEBI record. An exact InChIKey match was used to connect the records. Molecular descriptors do not describe a supplied product’s purity, particle size or performance.

Names & structural identifiers

Copy any identifier
busulfan
butane-1,4-diyl dimethanesulfonate
COVZYZSDYWQREU-UHFFFAOYSA-N
CS(=O)(=O)OCCCCOS(C)(=O)=O
InChI=1S/C6H14O6S2/c1-13(7,8)11-5-3-4-6-12-14(2,9)10/h3-6H2,1-2H3

Names & synonyms

Bisulfexbusulfanobusulfanumbutane-1,4-diyl dimethanesulfonateLeucosulfanMablinMielucinMisulbanMitostanMyeloleukonMyleran

Names are supplied by ChEBI. Trade names and related synonyms may describe a broader product context.

Classification & relationships

ChEBI ontology

Roles recorded in ChEBI

alkylating agentantifibrotic agentantineoplastic agentanticoagulantcarcinogenic agentteratogenic agentanti-HIV agentinsect sterilantanti-anaemic agent

Database role annotations describe reported biological or chemical roles; they are not product approvals or recommendations for use.

Safety classification · Japan

NITE / Japanese government
Japan · FY2009 source classification
Busulfan · 21A3728
EndpointReported classification
Acute toxicity (Oral)Category 3
Germ cell mutagenicityCategory 1B
CarcinogenicityCategory 1A
Reproductive toxicityCategory 1A
Specific target organ toxicity - Single exposureCategory 2 (blood system, nervous system, lung, liver)
Specific target organ toxicity - Repeated exposureCategory 2 (blood system, lung, eye, skin, systemic toxicity)

Selected source-reported endpoints. Other endpoints, rationales and conditions remain in the original classification. Missing or unlisted information does not mean non-hazardous. This is not a global classification or transport decision.

Read the original NITE classification

Mass ↔ amount of substance

Calculated from sourced mass
Equivalent amount
0.00405999 mol

Uses 246.306 g/mol from ChEBI. Assumes the substance described by this record; no purity or concentration correction is applied.

Elemental composition

Theoretical mass fractions
O
Oxygen · 6 atoms
38.97%
C
Carbon · 6 atoms
29.26%
S
Sulfur · 2 atoms
26.04%
H
Hydrogen · 14 atoms
5.73%

Calculated theoretical mass fractions from the reported formula and PubChem periodic-table atomic masses. These are not assay or purity results.

Research & patent references

Selected source associations
The role of busulfan in bone marrow transplantation. ↗Medical oncology (Northwood, London, England) · 1999 Sep · PMID 10523796
Busulfan in hematopoietic stem cell transplantation. ↗Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation · 2009 May · PMID 19361744
US2917432 · Patent reference ↗Patent cross-reference supplied by ChEBI. Association alone does not establish claim scope.

Sources & record history

Checked 27 Sep 2026
EMBL-EBI ChEBI · CHEBI:28901

Release 255, 9 September 2026. ChEBI three-star (manually annotated) source entry. View original record ↗ · CC BY 4.0

NCBI PubChem · CID 2478 · retrieved 2026-09-27

PubCAS formats source data, connects references and computes explicitly labelled conversions. CAS cross-references are supplied by ChEBI; they do not constitute CAS verification or endorsement.